XPA impacts formation but not proteasome-sensitive repair of DNA-protein cross-links induced by chromate.
DNA-protein cross-links (DPCs) are caused by a large number of human carcinogens and anti-cancer drugs. However, cellular processes involved in decreasing a burden of these genotoxic lesions remain poorly understood. Here, we examined the impact of nucleotide excision repair (NER), which is a principal repair pathway for bulky DNA adducts, and the main cellular reducers on removal of chromium(VI)-induced DPC. We found that standard and ascorbate-restored cultures of isogenic XPA-null (NER deficient) and XPA-complemented human fibroblasts had very similar repair of Cr-DPC (60-65% average DPC removal after 24 h). However, XPA absence caused depletion of G1 and accumulation of G2 cells at low Cr(VI) doses, suggesting that Cr-DPC were not a significant cause of cell cycle perturbations. Interestingly, although pro-oxidant metabolism of Cr(VI) in glutathione-depleted cells generated significantly fewer DPC, they were repair resistant irrespective of the NER status of cells. Inhibition of proteasome activity by MG132 abolished DPC repair in both XPA-null and XPA-complemented cells. XPA loss caused two to three times higher initial DPC formation, demonstrating the importance of NER in removal of the precursor lesions. Our results indicate that human NER is not involved in removal of Cr-DPC containing non-histone proteins but it acts as a defence mechanism against these large lesions by preventing their formation. Therefore, individual differences in NER activity are expected to alter sensitivity but not persistence of DPC as a biomarker of hexavalent Cr.
Zecevic
Alma
A
Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912, USA.
Hagan
Elizabeth
E
Reynolds
Mindy
M
Poage
Graham
G
Johnston
Tatiana
T
Zhitkovich
Anatoly
A
D002840:Chromates / Q000633:toxicity*; D004247:DNA / Q000378:metabolism*; D018736:DNA Adducts / Q000378:metabolism; D004249:DNA Damage; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000378:metabolism*; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D009153:Mutagens / Q000633:toxicity*; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism*; D051760:Xeroderma Pigmentosum Group A Protein / Q000378:metabolism*
D002840:Chromates; D018736:DNA Adducts; D004268:DNA-Binding Proteins; D009153:Mutagens; D051760:Xeroderma Pigmentosum Group A Protein; D004247:DNA; D046988:Proteasome Endopeptidase Complex
Carcinogenesis. 1995 Jul;16(7):1557-63
7614689
Chem Res Toxicol. 2004 Nov;17(11):1452-8
15540943
J Biol Chem. 2004 Jul 16;279(29):30419-24
15087443
J Biol Chem. 2009 Oct 2;284(40):27065-76
19674975
Mol Cell. 2007 Oct 12;28(1):147-58
17936711
Cancer Res. 1993 Feb 1;53(3):460-3
8425177
Free Radic Biol Med. 2006 Jun 1;40(11):1981-92
16716899
J Biol Chem. 2004 Feb 6;279(6):4250-9
14645247
Mol Cell Biochem. 2005 Nov;279(1-2):85-95
16283517
Chem Res Toxicol. 2010 Feb 15;23(2):341-7
19877617
Mutat Res. 2006 Nov 7;610(1-2):74-84
16857421
Mol Cell Biol. 2007 Oct;27(20):7089-101
17682057
Prog Nucleic Acid Res Mol Biol. 2005;79:183-235
16096029
Mol Cell Biol. 2005 May;25(9):3596-607
15831465
DNA Repair (Amst). 2009 Oct 2;8(10):1207-14
19625222
Chem Res Toxicol. 2005 Jan;18(1):3-11
15651842
Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4056-61
16537484
Toxicol Lett. 2002 Feb 28;127(1-3):47-54
12052640
Mutat Res. 2005 Mar;589(2):111-35
15795165
Crit Rev Toxicol. 2006 Feb;36(2):155-63
16736941
Mutagenesis. 2003 Jan;18(1):19-24
12473731
Curr Med Chem. 2004 Apr;11(8):1041-64
15078165
Biochemistry. 2002 Mar 5;41(9):3156-67
11863455
Cancer Res. 1983 Dec;43(12 Pt 1):5662-7
6640521
Carcinogenesis. 1998 Mar;19(3):413-8
9525274
Carcinogenesis. 1998 Aug;19(8):1401-7
9744536
Mutat Res. 1998 May 25;400(1-2):233-44
9685658
Biogerontology. 2002;3(1-2):95-102
12014851
Mutagenesis. 2000 Jan;15(1):85-90
10640535
J Toxicol Environ Health. 1997 Apr 11;50(5):433-49
9140463
Carcinogenesis. 1992 Aug;13(8):1485-9
1499101
Oncol Rep. 1996 May;3(3):439-41
21594388
Carcinogenesis. 2007 Jul;28(7):1613-20
17301063
Nucleic Acids Res. 2007;35(2):465-76
17169990
Cancer Res. 2009 Feb 1;69(3):1071-9
19141647
Microbiology (Reading). 2005 Jun;151(Pt 6):1939-1948
15942001
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1905-9
11842222
Aquat Toxicol. 2006 Jun 10;78(1):27-31
16672167
Environ Health Perspect. 1991 May;92:45-52
1935851
Mol Cell Biochem. 2001 Jun;222(1-2):107-18
11678591
Environ Health Perspect. 1998 Aug;106 Suppl 4:969-74
9703480
Biochemistry. 2003 Feb 4;42(4):1062-70
12549927
Mutat Res. 2006 Jul 25;599(1-2):116-23
16564059
J Biol Chem. 2007 Aug 3;282(31):22592-604
17507378
Mol Pharmacol. 1986 Jun;29(6):606-13
3713704
Free Radic Biol Med. 2009 Nov 15;47(10):1477-85
19703554
Mutat Res. 2008 Jan 1;637(1-2):161-72
17868748
Mutat Res. 1999 Mar 8;424(1-2):97-106
10064853
Carcinogenesis. 1992 Aug;13(8):1319-24
1499083
Chem Res Toxicol. 2008 Jan;21(1):28-44
17970581
Chem Res Toxicol. 2009 Jun;22(6):1069-76
19364102
Carcinogenesis. 2000 Aug;21(8):1573-80
10910961
Carcinogenesis. 2004 Mar;25(3):455-62
14604891